Status:
COMPLETED
Electronic Alerts for Heart Failure Prevention in Diabetes
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Heart Failure
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality. Recent therapeutic advances in pharmacotherapies, such ...
Detailed Description
Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality. Even despite adequate glycemic control, individuals wit...
Eligibility Criteria
Inclusion
- Providers in a General Internal Medicine outpatient clinic encounter
- Providers in a subspecialty Internal Medicine outpatient clinic encounter
- Providers in family medicine outpatient clinic encounter
Exclusion
- Providers in an inpatient hospital encounter
- Patients with HF or on SGLT-2i
Key Trial Info
Start Date :
March 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2024
Estimated Enrollment :
1524 Patients enrolled
Trial Details
Trial ID
NCT04791826
Start Date
March 25 2021
End Date
May 7 2024
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390